Literature DB >> 34231476

Systolic Blood Pressure Mediates Body Mass Index and Non-alcoholic Fatty Liver Disease: A Population-Based Study.

Xue Guan1, Qian Zhang1, Jie Xing1, Shuohua Chen2, Shouling Wu2, Xiujing Sun1.   

Abstract

BACKGROUND: Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases. Systolic blood pressure (SBP) and body mass index (BMI) are associated with NAFLD. We aimed to evaluate the mediating effect of SBP in the association between BMI and NAFLD.
METHODS: A total of 21 072 participants were enrolled. Multivariate logistic regression and linear regression models were used to describe the association between BMI, SBP, and NAFLD. The impact of SBP on the association between BMI and NAFLD was determined through mediation analysis.
RESULTS: BMI was positively associated with incident NAFLD overall (odds ratio (OR) = 1.171, 95% CI (1.153-1.189)) and in the female (OR = 1.189, 95% CI (1.157-1.222)) and male groups (OR = 1.162, 95% CI (1.141-1.184)) (P < .001). SBP also showed positive effects in the general, female, and male groups (P < .001). The effect of BMI on SBP also indicated similar positive results in the general (β = 0.913, 95% CI (0.799-1.026)), female (β = 0.956, 95% CI (0.760-1.151)), and male (β = 0.867, 95% CI (0.727-1.006)) groups (P < .001). Mediation analysis showed that SBP contributed to 14.23% of the relationship between BMI and NAFLD in the general group and 31.07 and 22.67% of the relationship in the female and male groups of individuals younger than 50 years old, respectively. The mediation effect appeared higher among females than among males, especially in participants younger than 50 years.
CONCLUSION: SBP and BMI contribute to the development of NAFLD. SBP mediates a positive association between BMI and NAFLD among individuals younger than 50 years, especially among females.

Entities:  

Mesh:

Year:  2021        PMID: 34231476      PMCID: PMC8975508          DOI: 10.5152/tjg.2021.20641

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  28 in total

Review 1.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  [The risk predictive value of high sensitivity C-reactive protein level for new hemorrhagic stroke events].

Authors:  Jie Zhu; Shou-ling Wu; Yan-xiu Wang; Jian-li Wang; Hong-tao Zhao; Guo-sheng Hou; Dong-qing Li; Cheng Jin; Jin-feng Li; Yan-rong Di
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2010-06

3.  Sleep and CKD in Chinese Adults: A Cross-Sectional Study.

Authors:  Junjuan Li; Zhe Huang; Jinhong Hou; Amy M Sawyer; Zhijun Wu; Jianfang Cai; Gary Curhan; Shouling Wu; Xiang Gao
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-07       Impact factor: 8.237

Review 4.  Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension.

Authors:  Georg B Ehret
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

5.  The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Takayuki Nakagawa; Hiroya Taniguchi; Kota Fujii; Tatsushi Omatsu; Tomoaki Nakajima; Hiroshi Sarui; Makoto Shimazaki; Takahiro Kato; Junichi Okuda; Kazunori Ida
Journal:  Ann Intern Med       Date:  2005-11-15       Impact factor: 25.391

6.  Longitudinal study of alcohol consumption and HDL concentrations: a community-based study.

Authors:  Shue Huang; Junjuan Li; Gregory C Shearer; Alice H Lichtenstein; Xiaoming Zheng; Yuntao Wu; Cheng Jin; Shouling Wu; Xiang Gao
Journal:  Am J Clin Nutr       Date:  2017-03-01       Impact factor: 7.045

Review 7.  Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.

Authors:  L Li; D-W Liu; H-Y Yan; Z-Y Wang; S-H Zhao; B Wang
Journal:  Obes Rev       Date:  2016-03-28       Impact factor: 9.213

8.  Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease.

Authors:  Sheng-Jie Wu; Hai Zou; Gui-Qi Zhu; Li-Ren Wang; Qi Zhang; Ke-Qing Shi; Ji-Bo Han; Wei-Jian Huang; Martin Braddock; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

9.  Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: Normal is not the new normal.

Authors:  Lin-Yan Qian; Jian-Fei Tu; Ya-Hui Ding; Jie Pang; Xian-Da Che; Hai Zou; Dong-Sheng Huang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

10.  Longitudinal Change in Fasting Blood Glucose and Myocardial Infarction Risk in a Population Without Diabetes.

Authors:  Cheng Jin; Shuohua Chen; Anand Vaidya; Yuntao Wu; Zhijun Wu; Frank B Hu; Penny Kris-Etherton; Shouling Wu; Xiang Gao
Journal:  Diabetes Care       Date:  2017-09-08       Impact factor: 19.112

View more
  2 in total

1.  Relationship between lifestyle and metabolic factors and carotid atherosclerosis: A survey of 47,063 fatty and non-fatty liver patients in China.

Authors:  Chun Zhang; Jiangang Wang; Siqing Ding; Gang Gan; Lijun Li; Ying Li; Zhiheng Chen; Yinglong Duan; Jianfei Xie; Andy S K Cheng
Journal:  Front Cardiovasc Med       Date:  2022-08-12

2.  Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement.

Authors:  Zengzhe Zhu; Ningning Yang; Hongmei Fu; Gang Yuan; Yong Chen; Tingting Du; Xinrong Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-16       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.